13
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T1634 | Glibenclamide | Glyburide | Potassium Channel , Mitochondrial Metabolism , CFTR , P-gp , Autophagy |
Glibenclamide (Glyburide) is an antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide. | |||
T26324 | VU0071063 | VU 0071063,VU-0071063 | Potassium Channel |
VU0071063 is a Kir6.2/SUR1 activator. | |||
T0816 | Acetohexamide | Acetohexamid,Dymelor,Gamadiabet | Potassium Channel , NADPH |
Acetohexamide (Acetohexamid) is an intermediate-acting, first-generation sulfonylurea with hypoglycemic activity. It inhibits sulfonylurea receptor 1 (SUR1) linked to the inwardly rectifying potassium channel (KIR6.2) wi... | |||
T16110 | ML418 | Potassium Channel | |
ML418 is a potent, selective and CNS penetrating Kir7.1 potassium channel blocker (IC50 = 310 nM), and also potently inhibits Kir6.2/SUR1. | |||
T0371 | Gliquidone | AR-DF 26,Glurenorm | Potassium Channel |
Gliquidone (AR-DF 26) is a potent, second-generation sulfonylurea with antihyperglycemic activity. Like other second-generation compounds, gliquidone exerts greater binding affinity to SUR1 and increased potency compared... | |||
T6587 | Mitiglinide Calcium | KAD-1229,S21403 | ATPase , Potassium Channel |
Mitiglinide Calcium (KAD-1229) is a blood glucose-lowering drugs, stimulating insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells. | |||
T1530 | Mitiglinide calcium hydrate | KAD-1229 calcium hydrate,Mitiglinide calcium,S-21403 calcium hydrate | Potassium Channel |
Mitiglinide calcium hydrate (S-21403 calcium hydrate) is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic ... | |||
T0127 | Glimepiride | Glimperide,HOE-490 | Potassium Channel |
Glimepiride (HOE-490) is a long-acting, third-generation sulfonylurea with hypoglycemic activity. | |||
T35635 | Rac-trans-4-hydroxy Glyburide | ||
rac-trans-4-hydroxy Glyburide is an active metabolite of the SUR1/Kir6.2 sulfonylurea inhibitor glyburide .1,2It is formed from glyburide by the cytochrome P450 (CYP) isoforms CYP2C8 and CYP2C9.1rac-trans-4-hydroxy Glybu... | |||
T17094 | Tifenazoxide | NN414 | Others |
Tifenazoxide is an effective and SUR1/Kir6.2 selective KATP channels opener. Tifenazoxide has an anti-diabetic effect, can inhibit glucose-stimulated insulin release in vitro and in vivo. | |||
T17240 | VU041 | Others | |
VU041 is an inhibitor of Anopheles gambiae and Aedes aegypti inward rectifier potassium 1 channels (IC50: 2.5 μM and 1.7 μM, respectively). VU041 inhibits appreciably is mammalian Kir2.1 (IC50: 12.7 μM) and has less inhi... | |||
T21431 | Mitiglinide | ||
Mitiglinide (KAD-1229) is an insulinotropic agent that is an ATP-sensitive K + (K ATP ) channel antagonist. Mitiglinide is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell K ATP channel). Mitiglinide ... | |||
T60428 | Cibenzoline | ||
Cibenzoline is an antiarrhythmic agent that inhibits the KATP channel by directly affecting the pore-forming Kir6.2 subunit rather than the SUR1 subunit. Cibenzoline shows little anticholinergic activity. Cibenzoline mar... |